Revised Abstract: """"""""COX-2 and DNA Methyltransferase Expression and Risk Factors for Bladder Cancer"""""""", is directed by Dr. Ronald K. Ross who seeks to identify key factors in human bladder carcinogenesis drawing on the results obtained in previous well-conducted epidemiologic trials. Dr. Ross will evaluate expression of two genes involved in two different pathways, namely COX-2 and DNMTs. Strengths of the project include the availability of a large existing epidemiologic database of confirmed bladder cancer patients with laboratory data on N-acetyltransferase (NAT) and glutathione-S-transferase (GST) genotypes, and access to tumor specimens for immunohistochemistry on the majority of these cases. The project investigators have extensive expertise in epidemiology and molecular and cellular biology. The strengths in combining molecular data with epidemiology are considerable, and there is a high likelihood of success in contributing significant knowledge to the field of bladder carcinogenesis. In the previous review numerous deficiencies were identified which reduced the overall scientific merit of this project. The deficiencies included lack of integration of the statistical analyses with Core B activities, lack of innovative statistical approaches to integrate biomarker results, lack of quality control in immunochemical staining, omission of two-sided power calculations for main effects and interactions, and extrapolation of results to development of a more comprehensive index of bladder cancer progression and risk. The applicants have revised their experimental approach and outline a plan for improved integration with Core B for the statistical analyses of data to be collected for this project. It was emphasized that Drs. Mimi Yu and Susan Groshen have a longstanding collegial relationship and will be meeting regularly for discussions regarding implementation of the research, quality control, and the analytic plan. Methods for exploring the co-expression of COX-2 and DNMTs are elaborated with stratification for smoking status, vitamin C intake, and other variables. A detailed description has been provided on validation of DNMT measurements and quality control issues regarding molecular analyses of the bladder cancer specimens. Dr. Debra Hawes has been added to the project to oversee quality control issues for immunohistochemical analysis in conjunction with Core C activities, which significantly improves the quality control of the project. Power calculations have been revised to include two-tailed tests of significance, and samples sizes appear sufficient to detect approximate 10 percent differences with sufficient statistical power. Sample size considerations are given in greater detail for not only the univariate comparisons, but also for examination of two-way and three-way interactions. There is also a plan to incorporate multivariate modeling of the data for tumor stage at detection to evaluation impact of the biomarkers on progression of bladder carcinogenesis. This project has been considerably improved since the last submission and received an average merit rating of 1.4.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA086871-01A2
Application #
6691378
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-13
Project End
2007-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Bartsch Jr, Georg; Mitra, Anirban P; Mitra, Sheetal A et al. (2016) Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder. J Urol 195:493-8
Catsburg, Chelsea E; Gago-Dominguez, Manuela; Yuan, Jian-Min et al. (2014) Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. Int J Cancer 134:125-35
Figueroa, Jonine D; Ye, Yuanqing; Siddiq, Afshan et al. (2014) Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet 23:1387-98
Figueroa, Jonine D; Han, Summer S; Garcia-Closas, Montserrat et al. (2014) Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis 35:1737-44
Fu, Yi-Ping; Kohaar, Indu; Moore, Lee E et al. (2014) The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res 74:5808-18
Corral, Roman; Lewinger, Juan Pablo; Van Den Berg, David et al. (2014) Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai. Int J Cancer 135:335-47
Mitra, Anirban P; Castelao, Jose E; Hawes, Debra et al. (2013) Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program. Cancer 119:756-65
Mitra, Anirban P; Hansel, Donna E; Cote, Richard J (2012) Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol 39:524-33
Davis-Dao, Carol A; Henderson, Katherine D; Sullivan-Halley, Jane et al. (2011) Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiol Biomarkers Prev 20:1156-70
Birkhahn, Marc; Penson, David F; Cai, Jie et al. (2011) Long-term outcome in patients with a Gleason score ýýý 6 prostate cancer treated by radical prostatectomy. BJU Int 108:660-4

Showing the most recent 10 out of 33 publications